Pharmaceutical company Sinclair has achieved record sales for 2023, with one million syringes of Ellansé being sold last year.
The company explains that this achievement reflects Ellansé’s global impact, as providers praise the products’ immediate volume, long-lasting results, skin quality improvement and safety record.
Dawn Thomson, Ellansé brand manager, said, “We are delighted to announce that one million syringes of Ellansé have been sold. This accomplishment highlights our commitment to providing best in class training and is a testament to Ellansé’s enviable results and safety record. We extend our thanks to our dedicated team, partners, KOLs and healthcare professionals who contributed to this incredible success.”
